Description : AstraZeneca is one of the world's leading pharmaceutical companies. Backed by a strong research base and extensive manufacturing and commercial skills, the company provides a powerful range of products for six important areas of healthcare - gastrointestinal, cardiovascular, cancer, respiratory, neurosciences and infection. With its headquarters based in UK, AstraZeneca has its R&D facilities basedin Sweden, USA, Japan & India. The company sells its products in over 100 countries, manufactures in 20 and has major research centres in 7. It employs over 60,000 people worldwide and values the diversity of skills and abilities that they bring to the business. R&D is based in Sweden, the UK, the USA, Canada, France, India & Japan. The company is recognised as having one of the best development pipelines in the industry and spends over $14 million each working day to maintain a flow of new medicines designed to meet patients’ needs. AstraZeneca invests over US$ 3.5 billion a year on R&D activities including Discovery Research. The company worldwide sales in 2003 totalled $18.8 billion.
AstraZeneca in India has its R & D, Manufacturing and Marketing offices in Bangalore, thus bringing to India an entire package of experience and investment in the people of Karnataka and of course Bangalore.

AstraZeneca India Pvt. Limited (AZIPL) is an integral part of the global organisation with a mandate to discover new chemical entities for the treatment of infectious diseases of the developing world. The Company, with its new, state-of-the-art facility in Bangalore, is dedicated to the “ Discovery of Novel Therapies for the developing world diseases”, an unique and brave commitment from the leading pharmaceutical company in the world, a recognition of the talent in India and the environment at Bangalore, a pledge to work together to combat diseases of the developing world like Tuberculosis, which needs a major research thrust to find newer therapies.

The R&D facility in AstraZeneca India has scientists of international repute working together as a team, contributing effectively to the goal of discovering new and novel therapeutic agents.

AstraZeneca Research Foundation India (AZREFI) organizes seminars, symposia and workshops on subjects at the cutting edge of biomedical and pharmaceutical sciences thereby supporting education and technological innovation in these areas.

AstraZeneca Pharma India Limited (AZPIL) the Marketing Company, has interests in six crucial areas of healthcare: Cardiovascular (with products like ‘Betaloc’, ‘Seloken XL’, ‘Imdur’, ‘Ramace’ & ‘Plendil’; Respiratory ( with products like ‘Symbicort’ & ‘Rhinocort’ ), Maternal Health Care (‘Prostodin’, ‘Cerviprime’ & ‘Primiprost’); Oncology (‘Zoladex’ & ‘Arimidex’) ; Infection (‘Meronem’), Neuroscience (‘Xylocaine’ & ‘Sensorcaine’). Competent research professionals and state-of-the-art laboratory facilities constantly improve and develop products and services to serve the Indian market better. The company maintains a high ethical standard of business practice. Products are promoted in a systematic & disciplined manner through the scientific dissemination of information to the medical fraternity.

AZPIL’s manufacturing facility spread across 70 acres of lush, green environs at Yelahanka, Bangalore, has been rated as one of the finest in South East Asia. It has a sophisticated production facility designed to meet the most stringent international standards, conforming to WHO cGMP (current Good Manufacturing Practices) norms. The Company has been awarded the Quality Excellence Award, bestowed by the Indian Drug Manufacturing Association (IDMA) for five consecutive years and seven times to date.